$9.18 $0.09 per serving
Product analysis
Ginkgo Biloba 120 mg may offer limited support for attention, although results are mixed and do not provide a dependable expectation of better everyday concentration.
AI assessment of the formula, label and price. How scoring works
Nutrient Quality40
The extract has named plant-compound markers, but these do not identify a particular researched preparation. Its quality and absorption cannot be compared confidently from those markers alone.
Ingredient Transparency80
The ginkgo amount and named plant-compound markers are stated. The detailed composition remains undisclosed, limiting comparisons between extracts.
Value For Money40
There is not enough information to judge the ginkgo contribution for value confidently. The named markers do not establish an equivalent preparation for a meaningful comparison.
Customer Satisfaction89
Customer ratings are positive across a very large number of reviews. The volume provides a broad view of satisfaction.
Product Focus58
The single ingredient keeps the focus on ginkgo, with limited and mixed support for attention. The serving and named markers do not establish reliable everyday cognitive or vision benefits.
- Format
Capsule - Container
- 100 Capsule(s)
- Per serving
- $0.09
- Also available
Ginkgo Biloba 60 mg$9.11- Customer rating
- 4.6 · 20,024 ratings
Goals
Impact
Moderate effect
Ginkgo at 120 mg has a limited, situation-dependent relationship with cognitive performance. The supplied findings focus on brain energy processes, while the evidence remains mixed for broad benefits in healthy adults.
How this product is rated for Brain Health
Ingredient fit94
The relevant ingredients fit the goal, with the declared amounts and broader formula focus shaping their contribution.
Goal fit
The relevant ingredients give the formula a clear connection to brain health.
Dose adequacy
The assessed ingredient amount reaches the supplied comparison range.
Pathways43
The main assessed contribution is concentrated in brain energy processes.
Depth
The strongest saved finding concerns brain energy processes, with meaningful but limited coverage.
Breadth
The saved findings concentrate on brain energy processes, rather than several well-covered processes.
Evidence58
Ginkgo evidence is mixed and supports only a limited, situation-dependent contribution. The saved assessment recognizes the preparation for the ingredients included in this finding.
Evidence strength
Ginkgo evidence is mixed and supports only a limited, situation-dependent contribution.
Studied preparation
The saved assessment recognizes the preparation for the ingredients included in this finding.
Formulation logic100
The assessed ingredients need no additional partner, and no configured conflicts were found.
Partner coverage
The assessed ingredients can contribute without an additional required partner.
Conflicts
No configured ingredient conflict was identified in the supplied assessment.
Effective doses
The ingredients included in this saved finding meet its amount threshold.
Impact
Moderate effect
The 120 mg ginkgo extract serving is relevant mainly to preliminary attention-speed findings and brain blood flow. Its standardization markers alone do not identify the studied preparation, so expectations for sustained cognitive improvement should remain cautious.
How this product is rated for Cognitive Support
Ingredient fit94
The assessed ingredients are closely focused on cognitive support, although the formula is also linked to other goals. The assessed amount reaches the saved reference level.
Goal fit
The assessed ingredients are closely focused on cognitive support, although the formula is also linked to other goals.
Dose adequacy
The assessed amount reaches the saved reference level.
Pathways40
The strongest saved connection is cerebral blood flow, with moderate coverage. One cognitive pathway reaches the saved coverage threshold; the wider range of pathways remains uncovered.
Depth
The strongest saved connection is cerebral blood flow, with moderate coverage.
Breadth
One cognitive pathway reaches the saved coverage threshold; the wider range of pathways remains uncovered.
Evidence25
Ginkgo supplies the strongest saved evidence finding at the assessed amount; the scope of its actual cognitive evidence still matters. The assessed preparation is not identified as a studied preparation.
Evidence strength
Ginkgo supplies the strongest saved evidence finding at the assessed amount; the scope of its actual cognitive evidence still matters.
Studied preparation
The assessed preparation is not identified as a studied preparation.
Formulation logic100
The assessed ingredients can work alone or have their required partner. No configured ingredient conflict was found in the supplied assessment. All assessed ingredients reach the saved minimum amount threshold.
Partner coverage
The assessed ingredients can work alone or have their required partner.
Conflicts
No configured ingredient conflict was found in the supplied assessment.
Effective doses
All assessed ingredients reach the saved minimum amount threshold.
Impact
Moderate effect
Ginkgo at 120 mg provides the focus-related contribution. Evidence for attention is mixed, with selected acute findings that do not establish consistent everyday concentration benefits.
How this product is rated for Mental Focus
Ingredient fit94
Ginkgo is the sole focus-related active. The 120 mg ginkgo serving reaches the saved exposure comparison level.
Goal fit
Ginkgo is the sole focus-related active.
Dose adequacy
The 120 mg ginkgo serving reaches the saved exposure comparison level.
Pathways44
Brain energy supply is the main assessed route. Only brain energy supply reaches the saved coverage level.
Depth
Brain energy supply is the main assessed route.
Breadth
Only brain energy supply reaches the saved coverage level.
Evidence62
Ginkgo provides the strongest saved evidence contribution at a counted amount; the scope and limitations of its evidence still apply. Ginkgo matches the preparation category accepted in the saved assessment.
Evidence strength
Ginkgo provides the strongest saved evidence contribution at a counted amount; the scope and limitations of its evidence still apply.
Studied preparation
Ginkgo matches the preparation category accepted in the saved assessment.
Formulation logic100
The counted ingredients can contribute independently or have their required partner. The counted ingredient meets the saved minimum exposure comparison.
Partner coverage
The counted ingredients can contribute independently or have their required partner.
Conflicts
No configured ingredient conflict was identified in the saved assessment.
Effective doses
The counted ingredient meets the saved minimum exposure comparison.
Impact
Moderate effect
Ginkgo extract at 120 mg has mixed evidence for cognitive outcomes such as memory and attention. Its relevance to everyday productivity is limited, despite the declared flavone glycoside and terpene lactone standardization.
How this product is rated for Productivity Boost
Ingredient fit94
The assessed active ingredient is closely aligned with the goal, though it is also linked to other uses. The credited ingredients reach the full amounts used in the saved assessment.
Goal fit
The assessed active ingredient is closely aligned with the goal, though it is also linked to other uses.
Dose adequacy
The credited ingredients reach the full amounts used in the saved assessment.
Pathways13
The strongest saved contribution relates to synaptic plasticity and neuroprotection, with limited coverage. No selected pathway reaches the saved threshold for substantial coverage.
Depth
The strongest saved contribution relates to synaptic plasticity and neuroprotection, with limited coverage.
Breadth
No selected pathway reaches the saved threshold for substantial coverage.
Evidence53
Ginkgo provides the strongest evidence among the ingredients at an assessed effective amount, with limited applicability to actual work output. The saved findings recognize the assessed effective ingredients as studied preparations.
Evidence strength
Ginkgo provides the strongest evidence among the ingredients at an assessed effective amount, with limited applicability to actual work output.
Studied preparation
The saved findings recognize the assessed effective ingredients as studied preparations.
Formulation logic100
The credited ingredients can contribute independently or have their required partners. No configured ingredient conflicts were recorded in the saved findings. All credited ingredients meet the saved minimum for a meaningful amount.
Partner coverage
The credited ingredients can contribute independently or have their required partners.
Conflicts
No configured ingredient conflicts were recorded in the saved findings.
Effective doses
All credited ingredients meet the saved minimum for a meaningful amount.
Impact
Moderate effect
Whether ginkgo improves routine vision is unclear. Results concerning normal-tension glaucoma involve a specific eye condition and particular extracts, so they don't give a dependable expectation for everyday vision from this preparation. A declared ginkgo amount alone can't resolve that difference.
How this product is rated for Eye Health
Ingredient fit74
Ginkgo preparations differ, and benefit for routine vision remains unclear.
Goal fit
Ginkgo preparations differ, and benefit for routine vision remains unclear.
Dose adequacy
Ginkgo 120 mg per serving. These amounts alone don't show a vision benefit.
Pathways40
A possible circulation-related role does not show that ginkgo improves everyday vision.
Depth
A possible circulation-related role does not show that ginkgo improves everyday vision.
Breadth
A possible circulation-related role does not show that ginkgo improves everyday vision.
Evidence64
Ginkgo preparations differ, and benefit for routine vision remains unclear.
Evidence strength
Ginkgo preparations differ, and benefit for routine vision remains unclear.
Studied preparation
The declared ingredient forms do not, by themselves, imply a vision benefit.
Formulation logic100
The declared ingredients have no particular identified conflict. A matching amount or form alone cannot show that everyday vision will improve.
Partner coverage
No missing ingredient partner is identified; this does not turn individual ingredients into a proven beneficial combination.
Conflicts
No particular ingredient conflict is identified for this serving.
Effective doses
Ginkgo 120 mg per serving. These amounts alone don't show a vision benefit.
Ingredients
| Ingredient | Amount per serving | Score |
|---|---|---|
Ginkgo biloba extract (Ginkgo Flavone Glycosides, Terpene Lactones) | 120 mg |
The serving lists 120 mg of ginkgo leaf extract. The saved details report 24% flavones and 6% terpenes for that preparation.
How this ingredient is rated
Composition and Label Disclosure70
The saved details report 24% flavones and 6% terpenes for the ginkgo preparation. The saved facts contain no qualifying ginkgolic-acid limit declaration; they do not establish its concentration.
Marker and Preparation Disclosure
The saved details report 24% flavones and 6% terpenes for the ginkgo preparation.
Declared Ginkgolic Acid Limit
The saved facts contain no qualifying ginkgolic-acid limit declaration; they do not establish its concentration.
Composition and Label Disclosure100
The serving lists 120 mg of ginkgo leaf extract.
Individual Preparation Amount Disclosure
The serving lists 120 mg of ginkgo leaf extract.
Commercial Price and Usability
The evaluation does not include a price comparison for ginkgo.
Alternative products
Report alternatives
Sources
Published studies used for the product analysis and the top-ranked studies for each ingredient and goal.
- Efficacy and adverse effects of ginkgo biloba for cognitive impairment and dementia: a systematic review and meta-analysis.
- Efficacy of Ginkgo biloba extract EGb 761® in dementia with behavioural and psychological symptoms: A systematic review.
- Ginkgo biloba extract EGb 761 is safe and effective in the treatment of mild dementia - a meta-analysis of patient subgroups in randomised controlled trials.
- Ginkgo biloba extract EGb 761® improves cognition and overall condition after ischemic stroke: Results from a pilot randomized trial.
- Ginkgo biloba extract EGb 761® in dementia with neuropsychiatric features: a randomised, placebo-controlled trial to confirm the efficacy and safety of a daily dose of 240 mg.
- Efficacy of ginkgo diterpene lactone meglumine on cognitive function in patients with acute ischemic stroke: a predefined exploratory analysis of a multicenter, double-blind, randomized controlled trial.
- A placebo-controlled, double-blind, randomized trial of an extract of Ginkgo biloba for dementia. North American EGb Study Group.
- Alleviating neuropsychiatric symptoms in dementia: the effects of Ginkgo biloba extract EGb 761. Findings from a randomized controlled trial.
- Efficacy and safety of a once-daily formulation of Ginkgo biloba extract EGb 761 in dementia with neuropsychiatric features: a randomized controlled trial.
- Effect of Ginkgo biloba extracts in the prevention of posterior capsule opacification after cataract surgery: A randomized clinical trial.
- Effect of Ginkgo biloba extract on preexisting visual field damage in normal tension glaucoma.
- [Ginkgo extract in impaired vision--treatment with special extract EGb 761 of impaired vision due to dry senile macular degeneration].
- Short-term effects of Ginkgo biloba extract on peripapillary retinal blood flow in normal tension glaucoma.
- [The course of color vision in early diabetic retinopathy treated with Ginkgo biloba extract. A preliminary double-blind versus placebo study].
- Ginkgo biloba Extract EGb 761 in the Treatment of Patients with Mild Neurocognitive Impairment: A Systematic Review.
- Proof of efficacy of the Ginkgo biloba special extract EGb 761 in outpatients suffering from mild to moderate primary degenerative dementia of the Alzheimer type or multi-infarct dementia.
- Proof of efficacy of the ginkgo biloba special extract EGb 761 in outpatients suffering from mild to moderate primary degenerative dementia of the Alzheimer type or multi-infarct dementia.
- Ginkgo biloba extract improved cognitive and neurological functions of acute ischaemic stroke: a randomised controlled trial.
- Ginkgo biloba in the Aging Process: A Narrative Review.
- [Ginkgo biloba extract EGb 761 in the treatment of dementia: evidence of efficacy and tolerability].